Mark A. Kay - Director at LogicBio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
LOGC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Mark A. Kay since 11/21/2023

Holdings reported by Mark A. Kay for LogicBio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $2.01 Nov 16, 2022 Direct
Stock Option (right to buy) 0 Nov 16, 2022 Direct Common Stock

Transactions reported by Mark A. Kay for LogicBio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.